Pesticides and metals induced Parkinson's disease: Involvement of free radicals and oxidative stress

Cellular and Molecular Biology

Volumn 53, Issue 5, 2007, Pages 19-28

  Singh, C ^a   Ahmad, I ^a   Kumar, A ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Free radicals; Metals; Oxidative stress; Parkinson's disease; Pesticides

Indexed keywords

ANTIOXIDANT; FREE RADICAL; METAL; PESTICIDE;

ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; RISK FACTOR; ANIMAL; BIOLOGICAL MODEL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALIA;

ANIMALS; FREE RADICALS; HUMANS; METALS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PARKINSON DISEASE; PESTICIDES;

EID: 34447271264     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T815     Document Type: Article

References (125)

1. Ara, J., Przedborski, S., Naini, A.B., Jackson-Lewis, V., Trifiletti, R.R., Horwitz, J, et al., Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Proc Natl. Acad. Sci. USA, 1998, 95: 7659-63.
2. Archibald, F.S. and Tyree, C., Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch. Biochem. Biophys. 1987, 256: 638-650.
3. Barlow, B.K., Lee, D.W., Cory-Slechta, D.A. and Opanashuk, L.A., Modulation of antioxidant defense systems by the environmental pesticide maneb in dopaminergic cells. Neurotoxicology 2005, 26 (1): 63-75.
4. Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V. and Greenamyre, J.T., Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3: 1301-1306.
5. Betarbet, R., Sherer, T.B. and Greenamyre, J.T., Animal models of Parkinson's disease. Bioessays 2002, 24: 308-318.
6. Betarbet, R., Sherer, T.B. and Greenmayer, J. T., Ubiquitin-proteasome system and Parkinson's disease. Exp. Neurol. 2005, 191: S17-S27.
7. Chen, R., Gosavi, N.S., Langston, J.W. and Chan, P., Parkin mutations are rare in patients with young-onset parkinsonism in a US population. Parkinsonism Relat Disord. 2003, 9: 309-12.
8. Chiueh, C.C., Andoh, T., Lai, A.R., Lai, E., Krishna, G. Neuroprotective strategies in Parkinson's disease: Protection against progressive nigral damage induced by free radicals. Neurotox. Res. 2000, 2(2-3): 293-310.
9. Choi, D.W., Yokoyama, M. and Koh, J., Zinc neurotoxicity in cortical cell culture. Neuroscience 1988, 24: 67-79.
10. Chun, H.S., Gibson, G.E., De Giorgio, L.A., Zhang, H., Kidd, V.J., Son, J.H., Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 2001, 76:1010-21.
11. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M., Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 2001, 7: 1144-1150.
12. Ciechanover, A., Linking ubiquitin, parkin and synphilin-1. Nat. Med. 2001, 7: 1108-9.
13. Clejan, L. and Cederbaum, A.I., Synergistic interaction between NADPH-cytochrome P-450 reductase, paraquat and iron in the generation of active oxygen radicals. Biochem. Pharmacol. 1989, 38:1779-86.
14. Corti, O. and Brice, A., Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease. J. Soc. Biol. 2002, 196: 95-100.
15. Corti, O. and Brice, A., Parkinson's disease: what have we learned from the genes responsible for familial forms? Med. Sci. Paris, 2003, 19: 613-619.
16. Dawson, T.M. and Dawson, V.L., Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302: 819-822.
17. Dexter, D.T., Wells, F.R., Agid, F., Agid, Y., Lees, A.J., Jenner, P. and Marsden, C.D., Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987, 2: 1219-1220.
18. Dexter, D.T., Wells, F.R., Agid, F., Agid, Y., Lees, A.J., Jenner, P. and Marsden, C.D., Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 1989, 52: 1830-1836.
19. Dexter, D.T., Carayon, A., Javoy-Agid, F., Agid, Y., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P. and Marsden, C.D., Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114(4): 1953-75.
20. Di Monte, D.A., Lavasani, M. and Manning-Bog, A.B., Environmental factors in Parkinson's disease. Neurotoxicology 2002, 23: 487-502.
21. Di Monte D.A., The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2003, 2: 531-8.
22. Dinis-Oliveira, R.J., Remião, F., Carmo, H., Duarte, J.A., Sánchez Navarro, A., Bastos, M. L. and Carvalho, F., Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 2006, 27(6): 1110-22.
23. Domico, L. M., Zeevalk, G. D., Bernard, L. P. and Cooper, K. R., Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction. Neurotoxicology 2006, 27: 816-825.
24. Fernandez, Y., Subirade, I., Anglade, F., Periquet, A. and Mitjavila, S., Microsomal membrane peroxidation by an Fe3+/paraquat system. Consequences of phenobarbital induction. Biol. Trace. Elem. Res. 1995, 47: 9-15.
25. Fleming, L., Mann, J.B., Bean, J., Briggle, T. and Sanchez-Ramos, J.R., Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol. 1994, 36:100-3.
26. Forno, L. S., Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 1996, 55: 259-272.
27. Fukushima, T., Yamada, K., Isobe, A., Shiwaku, K. and Yamane, Y., Mechanism of cytotoxicity of paraquat. I. NADH oxidation and paraquat radical formation via complex I. Exp. Toxicol Pathol. 1993, 45: 345-9.
28. Gao, H.M., Liu, B. and Hong, J.S., Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 2003, 23(15): 6181-6187.
29. Gasser, T., Genetics of Parkinson's disease. J. Neurol. 2001, 248: 833- 840.
30. Gerlach, M., Ben-Shacher, D., Riederer, P. and Youdim, M.B.H., Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 1994, 63: 793-807.
31. Giasson, B.I. and Lee, V.M., Are ubiquitination pathways central to Parkinson's disease? Cell 2003, 114: 1-8.
32. Giasson, B.I. and Lee, V.M., Parkin and the molecular pathways of Parkinson's disease. Neuron 2001, 31: 885-8.
33. -. J. Free Rad. Biol. Med. 1986, 2: 3-11.
34. Gorell, J.M., Ordidge, R.J., Brown, G.G., Deniau, J.C., Buderer, N.M. and Helpern, J.A., Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995, 45(6): 1138-43.
35. Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.L., Kortsha, G.X., Brown, G.G. and Richardson, R.J., Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997, 48(3): 650-658.
36. Gorell, J.M., Johnson, C.C. Rybicki, B.A., Peterson, E.L. and Richardson, R.J., The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998, 50: 1346-50.
37. Gorell, J.M., Johnson, C.C., Rybicki, B.A., Peterson, E.I., Kortsha, G.X., Brown, G.G., and Richardson, R.J., Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999, 20(2-3): 239-247.
38. Graham, D.G., Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 1984, 5: 83-96.
39. Greenamyre, J.T. and Hastings, T.G., Biomedicine. Parkinson's - divergent causes, convergent mechanisms. Science 2004, 304: 1120-1122.
40. Greenamyre, J.T., Betarbet, R., Sherer, T.B., The rotenone model of Parkinson's disease: genes, environment and mitochondria. Parkinsonism Relat, Disord. 2003, 9 (Suppl 2): S59-64.
41. Greenamyre, J.T., Sherer, T.B., Betarbet, R., Panov, A.V., Complex I and Parkinson's disease. IUBMB Life 2001, 52: 135-141.
42. Halbach, O.B., Schober, A., and Krieglstein, K., Genes, proteins, and neurotoxins involved in Parkinson's disease. Progress in Neurobiology 2004, 73: 151-177.
43. Hattori, N., Parkin gene: its mutations and function. Rinsho Shinkeigaku 2002, 42: 1077-81.
44. He, Y., Imam, S.Z., Dong, Z., Jankovic, J., Ali, S.F., Appel, S.H. and Le, W., Role of nitric oxide in rotenone-induced nigro-striatal injury. J. Neurochem. 2003, 86(6): 1338-1345.
45. Heikkila, R.E., Cabbat, F.S. and Cohen, G., In vivo inhibition of superoxide dismutasein mice by diethyldithiocarbamate. J. Biol. Chem. 1976, 251: 2182-2185.
46. Heinz, G.H., Hill, E.F., Contrera, J.F., Dopamine and norepinephrine depletion in ring doves fed DDE, dieldrin, and Aroclor 1254. Toxicol. Appl. Pharmacol. 1980, 53: 75-82.
47. Iannone, M., Ciriolo, M.R., Rotilio, G., and Nistico, G., Intra-nigral infusion of Cu-free superoxide dismutase prevents paraquat-induced behavioral stimulation and EcoG epileptogenic discharges in rats. Neuropharmacology 1991, 30: 893-898.
48. Jimenez-Jimenez, F.J., Molina, J.A., Aguilar, M.V., Meseguer, I., Mateos-Vega, C.J., Gonzalez-Munoz, M.J., de Bustos, F., Martinez-Salio, A., Orti-Pareja, M., Zurdo, M., Martinez-Para, M.C., Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease. J. Neural. Transm. 1998, 105: 497-505.
49. Jung, I.L. and Kim, I.G., Thiamine protects against paraquat-induced damage: scavenging activity of reactive oxygen species Environ. Toxicol. Pharmacol. 2003, 15: 19-26
50. Kamel, F. and Hoppin, J.A., Association of pesticide exposure with neurologic dysfunction and disease. Environ. Health Persp. 2004, 112: 950-8.
51. Kanthaswamy, A.G. and Wagner, J.R., Environmental factors-induced oxidative stress in dopaminergic degeneration: relevance to the etiopathogenesis of Parkinson's disease. Prominent Press, 2000.
52. Kanthaswamy, A.G., Kitazawa, M., Kanthaswamy, A. and Anantharam, V., Dieldrin-Induced Neurotoxicity: Relevance to Parkinson's Disease Pathogenesis. NeuroToxicology 2005, 26: 701-719.
53. Kim, Y.-H., Kim, E.Y., Gwag, B.J., Sohn, S. and Koh, J.-Y., Zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals. Neurosci. 1999, 89(1): 175-182.
54. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392: 605-8.
55. Kitazawa, M., Anantharam, V. and Kanthasamy, A.G., Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic. Biol. Med. 2001, 31: 1473-85.
56. Kuhn, W., Winkel, R., Woitalla, D., Meves, S., Przuntek, H. and Muller, T., High prevalence of Parkinsonism after occupational exposure to lead-sulfate batteries. Neurology 1998, 50(6): 1885-1886.
57. Kawanishi, S., Role of active oxygen species in metal-induced DNA damage. In: Handbook of Experimental Pharmacology, Vol 115, Toxicology of Metals-Biochemical Aspects, Goyer, R.A., Cherian, M.G. (eds.) Berlin, Springer-Verlag, 1995, pp. 349-371.
58. Lai, B.C.L., Marion, S.A., Teschke, K. and Tsui, J.K.C., Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Rel. Disord. 2002, 8: 297-309.
59. Landrigan, P. J., Sonawane, B., Butler, R. N., Trasande, L., Callan, R. and Droller, D., Early Environmental Origins of Neurodegenerative Disease in Later Life. Environmental Health Persp. 2005, 113 (9): 1230-1233.
60. Lang, A.E. and Lozano, A.M., Parkinson's disease. First of two parts. N. Engl. J. Med. 1998, 339: 1044-1053.
61. Langston, J.W., Ballard, P., Tetrud, J. W. and Irwin, I., Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219: 979-80.
62. Langston, J.W., Parkinson's disease: current and future challenges. Neurotoxicology 2002, 23: 443-50.
63. Lee, J.Y., Kim, J.H., Palmiter, R.D., Koh, J.Y., Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Exp. Neurol. 2003, 184: 337-347.
64. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998, 395: 451-2.
65. Levenson, C.W., Trace metal regulation of neuronal apoptosis: From genes to behaviour. Physiol. Behav. 2005, 86: 399-406.
66. Lindahl, P.E. and Oberg, K.E., The effect of rotenone on respiration and its point of attack. Experimental Cell Research 1961, 23: 228-237.
67. Liou, H.H., Tsai, M.C., Chen, C.J., Jeng, J.S., Chang, Y.C., Chen, S.Y., et al., Environmental risk factors and Parkinson's disease: a casecontrol study in Taiwan. Neurology 1997, 48:1583-8.
68. Liu, B., Gao, H. and Hong, J., Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Persp. 2003, 111: 1065-1073.
69. Lo, H.S., Chiang, H.C., Lin, A.M.Y., Chiang, H.Y., Chu, Y.C. and Kao, L.S., Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 2004, 17: 54- 61.
70. Lucking, C.B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., et. al., Association between early-onset Parkinson's disease and mutations in the parkin gene. New Engl. J. Med. 2000, 342(21): 1560-1567.
71. Maraganore, D.M., Farrer, M.J., Hardy, J.A., Lincoln, S.J., McDonnell, S.K. and Rocca, W.A., Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 1999, 53: 1858-60.
72. Marder, K., Logroscino, G., Alfaro, B., Mejia, H., Halim, A., Louis, E., et al., Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology 1998, 50: 279-81.
73. Marsden, C. D., Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1994, 57: 672-81.
74. McCormack, A.L., Thiruchelvam, M., Manning-Bog, A.B., Thiffault, C., Langston, J.W., Cory-Slechta, D.A., et al., Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 2002, 10: 19-27.
75. McGrew, D.M., Irwin, I., Langston, J.W., Ethylene-bis-dithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice. Neurotoxicology 2000, 21: 309-12.
76. Meco, G., Bonifati, V., Vanacore, N. and Fabrizio, E., Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis- dithiocarbamate). Scand. J. Work Environ. Health 1994, 20: 301-5.
77. Melchiorri, D., Reiter, R. J., Sewerynek, E., Hara, M., Chen, L. and Nisticdt, G., Paraquat Toxicity and Oxidative Damage REDUCTION BY MELATONIN. Biochem. Pharmacol. 1996, 51: 1095-1099.
78. Menegon, A., Board, P.G., Blackburn, A.C., Mellick, G.D., Le Couteur, D.G., Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998, 352: 1344-1346.
79. Miller, G.W., Erickson, J.D., Perez, J.T., Penland, S.N., Mash, D.C., Rye, D.B., Levey, A.I., Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Exp. Neurol. 1999a, 156:138-48.
80. Miller, G.W., Kirby, M.L., Levey, A.I., Bloomquist, J.R., Heptachlor alters expression and function of dopamine transporters. Neurotoxicology 1999b, 20:631-7.
81. Mocchegiani, E., Bertoni-Freddari, C., Marcellini, F. and Malavolta, M., Brain, aging and neurodegeneration: Role of zinc ion availability. Progress in Neurobiol. 2005, 75:367-390.
82. Mohanakumar, K.P., de Bartolomeis, A., Wu, R.M., Yeh, K.J., Sternberger, L.M., Peng, S.Y., Murphy, D.L. and Chiueh, C.C., Ferrous-citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. N. Y. Acad. Sci. 1994, 738: 392-399.
83. Mollace, V., Iannone, M., Muscoli, C., Palma, E., Granato, T., Rispoli, V., Nistico, R., Rotiroti, D. and Salvemini, D., The role of oxidative stress in paraquat-induced neurotoxicity in rats: protection by non peptidyl superoxide dismutase mimetic. Neurosci. Lett. 2003, 335(3): 163-166.
84. Montogmery, E.B., Heavy metals and etiology of Parkinson's disease and other movement disorders. Toxicology 1995, 97: 3-9.
85. Ngim, C.H. and Devathasan, G., Epidemiologic study on the association between body burden mercury level and idiopathic Parkinso's disease. Neuroepidemiology 1989, 8(3): 128-141.
86. Nuti, A., Ceravolo, R., Dell'Agnello, G., Gambaccini, G., Bellini, G., Kiferle, L., Rossi, C., Logi, C., Bonuccelli, U., Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy. Parkinsonism and Related Disorders 2004, 10: 481-485.
87. Patel, S., Singh, V., Kumar, A., Gupta, Y.K. and Singh, M.P., Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: Mechanism of neurodegeneration. Brain Res. 2006, 1081: 9-18.
88. Peng, J., Stevenson, F.F., Doctrow, S.R. and Anderson, J.K., Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantia nigra. J. Biol. Chem. 2005, 280(32): 29194-29198.
89. Polymeropoulos, M. H., Layedan, C., Leroy, E., Ide, S.E.,Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., et. al., Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997, 276: 2045-2047.
90. Popenoe, E.A. and Schmaeler, M.A., Interaction of human DNA polymerase β with ions of copper, lead and cadmium. Arch. Biochem. Biophys. 1979, 106: 190-201.
91. Priyadarshi, A., Khuder, S.A., Schaub, E.A. and Shrivastava, S., A metaanalysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 2000, 21: 435-40.
92. Ritz, B. and Yu, F., Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int. J. Epidemiol. 2000, 29: 323-9.
93. Schulte, P.A., Burnett, C.A., Boeniger, M.F., and Johnson, J., Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am. J. Public Health 1996, 86: 1281-8.
94. Seaton, T.A., Cooper, J.M. and Schapira, A.H., Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res. 1997, 777: 110-118.
95. Seidler, A., Hellenbrand, W., Robra, B. P., Vieregge P, Nischan P., Joerg, J., et al., Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996, 46: 1275-1284.
96. Sensi, S.L. and Jeng, J.M., Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. Curr. Mol. Med. 2004, 4: 87-111.
97. Sherer, T.B., Betarbet, R., Stout, A.K., Lund, S., Baptista, M., Panov, A.V., et. al., An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha- synuclein metabolism and oxidative damage. J. Neurosci. 2002, 22: 7006-15.
98. Sherer, T.B., Kim, J.H., Betarbet, R. and Greenamyrea J.T., Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp. Neurol. 2003, 179: 9-16.
99. Shimizu, K., Matsubara, K., Ohtaki, K. and Shiono, H., Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neurosci. Res. 2003a, 46: 523-32.
100. Shimizu, K., Matsubara, K., Ohtaki, K., Fujimaru, S., Saito, O. and Shiono, H., Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res. 2003b, 976: 243-52.
101. Singh, M.P., Patel, S., Dikshit, M. and Gupta, Y.K., Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease. Indian J. Biochem. Biophys. 2006, 43(2): 69-81.
102. Smargiassi, A., Mutti, A., De Rosa, A., De Palma, G., Negrotti, A. and Calzetti, S. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology 1998, 19: 709-12.
103. Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G.P., Hebenstreit, G. and Youdim, M.B., Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 1988, 74: 199-205.
104. Spencer, J.P., Jenner, A., Aruma, O.I., Evans, P.J. et. al., Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease. FEBS Lett. 1994, 353(3): 246-250.
105. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M., Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA, 1998, 95: 6469-6473.
106. Splittgerber, A.G. and Tappel, A.L., Inhibition of glutathione peroxidase by cadmium and other metal ions. Arch. Biochem. Biophys. 1979, 197: 534-542.
107. Steece-Collier, K., Maries, E. and Kordower, J. H., Etiology of Parkinson's disease: genetics and environment revisited. Proc Natl Acad Sci USA, 2002, 99:13972-4.
108. Stich, H.F., Wei, L. and Whiting, R.F., Enhancement of the chromosome-damaging action of some reducing agents. Cancer Res. 1979, 39: 4145-4151.
109. Suntres, Z.E., Hepworth, S.R., Shek, P.N., Protective effect of liposome-associated α-tocopherol against paraquat-induced acute lung toxicity. Biochem. Pharmacol. 1992, 44(9): 1811-1818.
110. Tada-Oikawa, S., Hiraku, Y., Kawanishi, M. and Kawanishi, S., Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis. Life Sciences 2003, 73: 3277-3288.
111. Tanner, C.M. and Goldman, S.M., Epidemiology of Parkinson's disease. Neuroepidemiology 1996, 14: 317-35.
112. Taylor, C.A., Saint-Hilaire, M.H., Cupples, L.A, Thomas, C.A., Burchard, A.E., Feldman R.G., et. al., Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am. J. Med. Genet. 1999, 88: 742-749.
113. 1134. Thiruchelvam, M., Brockel, B.J., Richfield, E.K., Baggs, R.B. and Cory- Slechta, D.A., Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res. 2000a, 873: 225-234.
114. Thiruchelvam, M., McCormack, A., Richfield, E.K., Baggs, R.B., Tank, A.W., Di Monte D.A., et. al., Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur. J. Neurosci. 2003, 18: 589-600.
115. Thiruchelvam, M., Richfield E.K., Baggs, R.B., Tank, A.W., Cory-Slechta, D.A., The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 2000b, 20: 9207-9214.
116. Thiruchelvam, M., Richfield, E.K., Goodman, B.M., Baggs, R.B. and Cory- Slechta, D.A., Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 2002, 23: 621-33.
117. Tsang, F. and Soong, T.W., Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease. IUBMB Life 2003, 55: 323-7.
118. Tuchsen, F. and Jensen, A.A., Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993. Scand. J. Work Environ. Health 2000, 26:359-362.
119. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M. and Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39(1): 44-84.
120. Valko, M., Rhodes, C.J., Moncol, J., Izakovic, M. and Mazur, M., Free radicals, metals and antioxidants in oxidatives stress-induced cancer. Chem. Biol. Interact. 2006, 160: 1-40.
121. Weiss, J.H., Sensi, S.L. and Koh, J.Y., Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol. Sci. 2000, 21: 395-401.
122. Wintermeyer, P., Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Berg, D., et. al., Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport 2000, 11: 2079-82.
123. Yamada, K. and Fukushima, T. Mechanism of cytotoxicity of paraquat. II. Organ specificity of paraquat-stimulated lipid peroxidation in the inner membrane of mitochondria. Exp Toxicol Pathol. 1993, 45: 375-80.
124. Zhang, J., Fitsanakis, V.A., Gu, G., Jing, D., Ao, M., Amarnath, V. and Montine, T.J., Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J. Neurochem. 2003, 84(2): 336-346.
125. Zheng, W., Ren, S. and Graziano, J.H., Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res. 1998, 799(2): 334-342.